Awareness-raising event in the pharmaceutical and medical fields: “Living with Illness. Living with Hope. Photo Exhibition: Toward a Future That Creates Answers Yet to Be Discovered”—Part 2 to be held in Osaka A joint photo exhibition with four organizations, photographed by Mr. Harvie Yamaguchi
March 6, 2024
The Japan Pharmaceutical Manufacturers Association (Chairman: Hiroaki Ueno; hereinafter “JPMA”), with the cooperation of the Japan Society of Clinical Oncology (a public interest incorporated association), the Japanese Cancer Association (a general incorporated association),the Japan Society for Cancer Therapy, and CancerX, will host a photography exhibition titleda photography exhibition titled “Living with Illness. Living with Hope. Photography Exhibition: Toward a Future That Creates Answers Yet to Be Found” (hereinafter referred to as “this exhibition”) at the Umeda Tsutaya Bookstore Showroom (Kita-ku, Osaka City) from Monday, March 25, 2024, to Sunday, March 31, 2024, to raise public awareness of social issues in the pharmaceutical and medical fields.
This photo exhibition is the second installment, following the one held in Harajuku, Tokyo, in December 2023. With the cooperation of four organizations, it features portraits and messages from patients, their families, cancer survivors, supporters,and healthcare professionals—who are facing illness from various perspectives while continuing to take on challenges without losing hope.
On the first day, an opening presentation featuring photographer Harvie Yamaguchi, who collaborated on this exhibition, and Hiroaki Ueno, Chairman of the JPMA, will be held at the Tsutaya Bookstore Share Lounge “Sky Area.”In addition to members of the media, we plan to set up a general viewing area on a first-come, first-served basis to help the public gain a deeper understanding of social issues in the pharmaceutical and medical fields. For general admission, participation tickets will be distributed starting at 10:30 a.m. on the day of the event in front of the Sky Area to the first 20 visitors (tentative).*Limited to one ticket per person.
At the venue, visitors during the event period were invited toan interactive display board where visitors can help complete the word “HOPE” by placing gerbera stickers—whose floral meaning is “hope”—on the board. Additionally, to spread awareness of this initiative to a wider audience, we’ll be encouraging participants to share their photos and feedback from the event using the hashtag “#LivingWithIllnessLivingWithHope.”
In conjunction with this event, we will be displaying poster advertisements primarily around JR Osaka Station and Hankyu Umeda Station in the Umeda area of Osaka.
Even with today’s advances in medicine, challenges such as “unmet medical needs”—including conditions for which no treatment has been found, no effective drugs have been developed, or treatment involves significant burdens—as well as issues known as “drug lag/loss,” where drugs approved overseas are not approved in Japan or are not even being developed here, still exist.Through this photo exhibition, the JPMA aims to contribute to raising awareness and promoting understanding of social issues in the pharmaceutical and medical fields.
Purpose of the Event
In the society we live in, there are people who face their illnesses every day, believing that the day will come when they can use the medication they hope for or when a cure will be found.For this photo exhibition, we have received cooperation from a wide range of individuals—including patients and their families, cancer survivors, those involved in patient support activities, as well as doctors, nurses, and pharmacists—to showcase, through photographs and messages, their resilience and hope as they live with their illnesses.At the same time, we have published an introduction to this photo exhibition on the JPMA website:
. We hope to raise awareness among the many people who are not directly affected by these issues regarding the challenges facing pharmaceuticals and healthcare, and to encourage a shift from indifference to concern and from misunderstanding to understanding.
Event Overview
| Dates | March 25 (Mon) – March 31 (Sun), 2024
|
|---|---|
| Hours
| 10:30 a.m.–9:00 p.m.
|
| Venue | Umeda Tsutaya Bookstore Address: 9th Floor, LUCUA ERE, 3-1-3 Umeda, Kita-ku, Osaka City, Osaka Prefecture Links: https://store.tsite.jp/umeda/access/ Access: JR West “Osaka Station” or “Kitashinchi Station”; Hankyu/Hanshin “Umeda Station”; Midosuji Line “Umeda Station”; Tanimachi Line “Higashi-Umeda Station”; Yotsubashi Line “Nishi-Umeda Station” |
| Admission Fee | Free |
| Organizer | Japan Pharmaceutical Manufacturers Association |
| In Cooperation With | Japan Society of Clinical Oncology (Public Interest Incorporated Association), Japanese Cancer Association (General Incorporated Association), Japanese Society for Cancer Therapy (General Incorporated Association), CancerX (General Incorporated Association) |
| Photo Exhibition Website | https://www.jpma.or.jp/information/public_affairs/pr/2023/photo/index.html |
<Overview of the Opening Presentation on the First Day (Open to the Public)>
| Date | Monday, March 25, 2024, 11:00 AM – 11:30 AM |
|---|---|
| Venue | Umeda Tsutaya Bookstore Share Lounge <Sky Area> |
| Admission | Free |
| How to Participate | Participation tickets will be distributed on a first-come, first-served basis to the first 20 people (estimated) starting at 10:30 a.m. in front of the Sky Area. *Limited to one ticket per person. |
| Speakers | Photographer Harvie Yamaguchi, Hiroaki Ueno, President of the JPMA, and others |
*Subject to cancellation or change without notice.
*Photography by the general public is prohibited during the event.
<Profile of Mr. Harvie Yamaguchi>
Born in Tokyo in 1950. After graduating from university, he moved to London in 1973 and spent 10 years there. While in London, he belonged to a theater troupe and worked as an actor, and at the same time encountered the emerging punk rock and new wave movements, experiencing one of the most exciting eras in London’s history.Since returning to Japan, he has turned his camera on many domestic artists—including Masaharu Fukuyama, Koji Yoshikawa, and Yutaka Ozaki—as well as ordinary people, creating a body of work characterized by monochrome snapshot portraits. Drawing on his experience of suffering from a long-term illness called caries during his childhood and adolescence, he has defined the theme of his photography as “capturing the hope of life.”He has many fans who appreciate his gentle and refined style, and he enjoys support from a wide range of age groups.
In addition to photography, he writes essays, hosts radio shows, and gives lectures; he has also provided lyrics for several songs by guitarist Tomoyasu Hotei.
Her major works include “LONDON AFTER THE DREAM,” “Daikanyama 17,” “HOPE: The Sky Turns Blue,” “What Makes a Good Photograph,” and “Photographs That Bring Happiness.”
Her pen name, “Harvey,” is derived from the jazz flutist Harvey Mann, whom she deeply admires.
Awards: 2011 Japan Photographic Society Artist Award.
Visiting Professor at Osaka University of Arts.
Mr. Herbie Yamaguchi
<Promotional Image for This Photo Exhibition>
Organization Overview
Japan Pharmaceutical Manufacturers Association (JPMA)
The JPMA is a voluntary organization comprising 71 research-and-development-oriented pharmaceutical companies (as of October 1, 2023).Established in 1968, the JPMA has contributed to global healthcare under the motto “Realizing Patient-Centered Healthcare” through the development of groundbreaking new prescription drugs.The JPMA carries out multifaceted initiatives, including addressing common issues facing the pharmaceutical industry, promoting a deeper understanding of pharmaceuticals, and fostering international collaboration. Furthermore, the Association is committed to the sound development of the pharmaceutical industry, particularly through strengthening policy formulation and advocacy, responding to globalization, and enhancing public relations efforts.
Japan Society of Clinical Oncology (Public Interest Incorporated Association)
The Japanese Society of Clinical Oncology is an organization established in 1993 with the goals of establishing medical oncology (internal oncology and clinical oncology) and promoting clinical research and clinical trials in cancer treatment. Currently operating as a Public Interest Incorporated Association, it is one of the sub-sections of the Japan Medical Association and has 8,900 members.The Society trains and certifies “Specialists in Cancer Chemotherapy”—experts in anticancer drugs who possess knowledge and skills in drug therapy for a wide range of cancers—and disseminates accurate information on cancer treatment and raises awareness among healthcare professionals and the general public through educational programs and public lectures.Japanese Society of Clinical Oncology official website: https://www.jsmo.or.jp/
Japan Cancer Society (General Incorporated Association)
The Japanese Cancer Association was established in 1941. It is an academic organization that aims to “contribute to the health and welfare of the public” by “contributing to the advancement of cancer research,” and has approximately 14,000 members (as of November 2023).Japanese Cancer Association official website: https://www.cancer.or.jp/
Japan Society for Cancer Therapy (General Incorporated Association)
The Japanese Society for Cancer Therapy was established in 1963. With 16,304 members (as of the end of July 2023), it is Japan’s largest academic organization specializing in cancer.It is a society where various healthcare professionals and researchers involved in cancer prevention, diagnosis, and treatment come together to identify current challenges in cancer care and research and discuss the future as a group. The society is also committed to activities aimed at realizing a society where cancer patients and their families can live with peace of mind and safety.Japan Society for Cancer Therapy official website: https://www.jsco.or.jp/
CancerX (General Incorporated Association)
CancerX is an organization where people from diverse backgrounds—including industry, academia, government, the private sector, and the medical field—join forces to tackle societal challenges related to cancer. It has been active as a member of the UICC (Union for International Cancer Control) since 2020.CancerX official website: https://cancerx.jp/